FDA Determines Regulatory Review Period for Cook GRII Coronary Stent Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for Cook's GRII Coronary Stent patent extension, as required by law, following a submission to the US Department of Commerce for patent extension of the medical device.